2024-11-01 2025-10-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 11640822 bus:FullAccounts 2024-11-01 2025-10-31 11640822 bus:Micro-entities 2024-11-01 2025-10-31 11640822 bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 11640822 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11640822 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11640822 2024-11-01 2025-10-31 11640822 2025-10-31 11640822 bus:RegisteredOffice 2024-11-01 2025-10-31 11640822 core:WithinOneYear 2025-10-31 11640822 core:AfterOneYear 2025-10-31 11640822 2023-11-01 11640822 bus:Director1 2024-11-01 2025-10-31 11640822 bus:Director1 2025-10-31 11640822 bus:Director1 2023-11-01 2024-10-31 11640822 bus:CompanySecretary1 2024-11-01 2025-10-31 11640822 bus:LeadAgentIfApplicable 2024-11-01 2025-10-31 11640822 2023-11-01 2024-10-31 11640822 2024-10-31 11640822 core:WithinOneYear 2024-10-31 11640822 core:AfterOneYear 2024-10-31 11640822 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 11640822 core:FurnitureFittings 2024-11-01 2025-10-31 11640822 core:FurnitureFittings 2025-10-31 11640822 core:FurnitureFittings 2024-10-31 11640822 core:ComputerEquipment 2024-11-01 2025-10-31 11640822 core:ComputerEquipment 2025-10-31 11640822 core:ComputerEquipment 2024-10-31 11640822 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-10-31 11640822 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-31 11640822 core:Goodwill 2024-11-01 2025-10-31 11640822 core:Goodwill 2025-10-31 11640822 core:Goodwill 2024-10-31 11640822 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 11640822 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 11640822 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 11640822 core:Non-currentFinancialInstruments 2025-10-31 11640822 core:Non-currentFinancialInstruments 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 11640822
England and Wales
Unaudited Financial Statements
for the year ended 31 October 2025
for
BIOPOISE CONSULTING LTD

BIOPOISE CONSULTING LTD ###### Statement of Financial Position As at 31 October 2025
|  | £ | 2025 £ |  | £ | 2024 £
--- | --- | --- | --- | --- | --- | ---
Fixed assets |  |  | 1,499 |  |  | 2,195
Current assets |  | 303,652 |  |  | 371,162 |
Creditors: amount falling due within one year |  | (2,223) |  |  | (8,367) |
Net current assets/(liabilities) |  |  | 301,429 |  |  | 362,795
Total assets less current liabilities |  |  | 302,928 |  |  | 364,990
Accruals and deferred income |  |  | (34) |  |  | 0
Net assets/(liabilities) |  |  | 302,894 |  |  | 364,990
Capital and reserves |  |  | 302,894 |  |  | 364,990
For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. Signed on behalf of the board of directors:
--------------------------------------------- Gbenga Olasehinde Director |  |
Date approved: 22 July 2026 1

BIOPOISE CONSULTING LTD ###### Notes to the Accounts For the year ended 31 Oct 2025
Statutory Information Biopoise Consulting Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 11640822, registration address 44 Crosby Road, Dagenham, RM10 9AS, United Kingdom. The presentation currency is £ sterling.
1. | Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2. | Average number of employees Average number of employees during the year was 1 (2024: 1).
3. | Director Advances Credits Note As at the 31 October 2025, the director owed £1,329.55 to Biopoise Consulting Ltd (£1,645.55 at 31 October 2024). The loan is interest-free, unsecured and has no set repayment terms.
2